Drug Makers Turn to Data Tools to Speed Up Costly Trials

Developing a new drug now costs companies around $41 million per major trial. H1, a company that helps match patients with research studies, just raised $40 million to tackle this problem. The platform helps pharmaceutical companies find doctors and hospitals willing to run trials faster, cutting costs and getting medicines to patients sooner.